Legal & General Group PLC Decibel Therapeutics, Inc. Transaction History

Legal & General Group PLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$6.6 - $9.04 $11,497 - $15,747	-1,742 Closed	0 $0
Q2 2021 Aug 12, 2021	SELL	$6.39 - $11.51 $5,910 - $10,646	-925 Reduced 34.68%	1,742 $15,000
Q1 2021 May 17, 2021	BUY	$10.56 - $19.9 $28,163 - $53,073	2,667 New	2,667 $31,000

Ticker DBTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,964,500
Description
Decibel Therapeutics, Inc., a clinical-stage biotechnology company, engages in discovering and developing transformative treatments for hearing and balance disorders. Its product candidates and programs focuses on three areas, such as Gene Therapies for Congenital, Monogenic Hearing Loss designed to restore functional cells within the cochlea to...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.